Arrow Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-240
| Closed | -$44K | – | 340 |
|
|
2021
Q2 | $44K | Hold |
240
| – | – | 0.01% | 226 |
|
|
2021
Q1 | $37K | Hold |
240
| – | – | ﹤0.01% | 231 |
|
|
2020
Q4 | $37K | Hold |
240
| – | – | 0.01% | 217 |
|
|
2020
Q3 | $27K | Hold |
240
| – | – | 0.01% | 227 |
|
|
2020
Q2 | $27K | Sell |
240
-60
| -20% | -$6.75K | 0.01% | 235 |
|
|
2020
Q1 | $27K | Hold |
300
| – | – | 0.01% | 236 |
|
|
2019
Q4 | $32K | Hold |
300
| – | – | 0.01% | 246 |
|
|
2019
Q3 | $29K | Sell |
300
-2,000
| -87% | -$193K | 0.01% | 247 |
|
|
2019
Q2 | $301K | Hold |
2,300
| – | – | 0.06% | 150 |
|
|
2019
Q1 | $311K | Buy |
2,300
+300
| +15% | +$40.6K | 0.07% | 149 |
|
|
2018
Q4 | $195K | Hold |
2,000
| – | – | 0.05% | 157 |
|
|
2018
Q3 | $278K | Buy |
+2,000
| New | +$278K | 0.06% | 157 |
|